Chester, CA, United States of America

Edward A Kiegle

USPTO Granted Patents = 10 

Average Co-Inventor Count = 14.4

ph-index = 5

Forward Citations = 58(Granted Patents)


Location History:

  • Malibu, CA (US) (2008)
  • Chester, CA (US) (2010)
  • Chester, VT (US) (2010 - 2020)
  • Schoharie, NY (US) (2023)

Company Filing History:


Years Active: 2008-2023

Loading Chart...
10 patents (USPTO):Explore Patents

Title: Edward A Kiegle: Innovator in Promoter Control Elements

Introduction

Edward A Kiegle is a notable inventor based in Chester, CA (US). He has made significant contributions to the field of biotechnology, particularly in the area of promoter control elements. With a total of 10 patents to his name, Kiegle's work has advanced our understanding of gene regulation.

Latest Patents

Kiegle's latest patents focus on promoter sequences and promoter control elements. One of his inventions is directed to polynucleotide constructs that comprise these promoters and control elements. The methods he developed allow for the identification of promoters, control elements, or fragments thereof. Furthermore, his inventions relate to the use of these promoters or promoter control elements to modulate transcript levels, which is crucial for various biotechnological applications.

Career Highlights

Throughout his career, Kiegle has worked with prominent companies in the biotechnology sector, including Ceres, Inc. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to innovative projects.

Collaborations

Some of Kiegle's notable coworkers include Yiwen Fang and Shing Kwok. Their collaborative efforts have likely played a role in the successful development of Kiegle's patents and innovations.

Conclusion

Edward A Kiegle's contributions to the field of biotechnology through his patents on promoter control elements highlight his role as an influential inventor. His work continues to impact the understanding and application of gene regulation in various biotechnological contexts.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…